Chemi-Verse™ CLK1 Kinase Assay Kit

Catalog #
82145
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Chemi-Verse™ CLK1 Kinase Assay Kit is designed to measure CLK1 (CDC2-like kinase 1) kinase activity for screening and profiling applications using ADP-Glo™ as a detection reagent. The assay kit comes in a convenient 96-well format, with enough purified recombinant CLK1 kinase (amino acids 129-end), kinase substrate, ATP, and kinase assay buffer for 100 enzyme reactions.

Synonyms
CLK, STY, CLK/STY
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Materials Required But Not Supplied
  • ADP-Glo™ Kinase Assay (Promega #V6930)
  • DTT (Dithiothreitol), 1M, optional
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator 
Format
Catalog # Name Amount Storage
40196 CLK1, GST-Tag* 2.5 µg -80°C
79334 5x Kinase Buffer 1 1.5 ml -20°C
79686 500 µM ATP 50 µl -20°C
78514 Myelin Basic Protein (MBP), 5 mg/ml 50 µl -20°C
79696 White 96-well plate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
P49759
Background

CDC-like kinase 1 (CLK1) is part of the dual-specificity protein kinase (DSK) family that phosphorylateserine/ arginine rich (SR) proteins that are part of the spliceosomal complex and regulate non-splicing proteins. It is involved in cell cycle progression, apoptosis, the DNA replication checkpoint, and regulation of telomere length. Dysfunctions in pathways regulated by CLK1 result in Alzheimer’s disease, Duchenne’s muscular dystrophy (DMD), viral replication, autophagy-associated diseases (diabetes, cardiovascular, and infectious diseases) and cancer. CLK1 is upregulated in prostate cancer, gastric, and pancreatic ductal adenocarcinoma. The use of TG003, a CLK1/2/4 inhibitor, leads to dystrophin exon31 skipping in cells from DMD patients, and a partially functional dystrophin protein. TG003 also decreases gastric and prostate cancer cell viability and migration. CLK1 inhibitors such as NIH39 and KH-CB19 showed anti-viral activity towards influenza A, and Leucettine L41 increases cellular autophagy in U-2 OS cells. The development of CLK1 inhibitors and a deeper understanding of its role in the multiple pathways where it is involved will prove crucial for the treatment of CLK1-linked diseases.

References

Song M., et al., 2023 Signal Transduction and Targeted Therapy 8: 148.